Print

Synageva BioPharma (GEVA) to Present at the 31st Annual J.P. Morgan Healthcare Conference  
12/20/2012 6:08:03 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, announced today its presentation at the upcoming J.P. Morgan Healthcare conference being held in San Francisco, CA.
//-->